Rare genetic disease in China: A call to improve clinical services Clinical

Orphanet Journal of Rare Diseases

Volumn 10, Issue 1, 2015, Pages

  Chopra, M ^a,b,c   Duan, T ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHINA; CLINICAL ASSESSMENT; CLINICAL GENETICS; DIAGNOSTIC TEST; DISEASE REGISTRY; DRUG LEGISLATION; EPIDEMIOLOGICAL DATA; FUNDING; GENETIC DISORDER; GENETIC SCREENING; GENOMICS; GENOTYPE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; INFANT MORTALITY; LETTER; LIFE EXPECTANCY; MEDICAL SPECIALIST; NEXT GENERATION SEQUENCING; PHENOTYPE; PRACTICE GUIDELINE; PRENATAL SCREENING; PUBLIC HEALTH; RARE DISEASE; TRANSLATIONAL RESEARCH; HEALTH CARE DELIVERY; HUMAN; PROCEDURES; RARE DISEASES; RURAL POPULATION; TRENDS;

CHINA; DELIVERY OF HEALTH CARE; HUMANS; RARE DISEASES; RURAL POPULATION;

EID: 84945910789     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/s13023-015-0333-7     Document Type: Letter

References (12)

1. Wang J, Goo J, Yang L, Zhang Y, Sun Z, Zhang Y. Rare Diseases and Legislation in China. Lancet. 2010;377:708-9.
2. Zhang YJ, Wang Y, Li L, Goo JJ, Wang JB. China's first rare-disease registry is under development. Lancet. 2011;378(9793):769-70.
3. Gong S, Jin S. Current progress in the management of rare diseases and orphan drugs in China. Intractable Rare Dis Res. 2012;1(2):45-52.
4. Zhao X, Wang P, Tao X, Zhong N. Genetic testing and services in China. J Community Genet. 2013;4:379-90.
5. China. Chinese health statistical digest. 2010. Ministry of Health http://www.moh.gov.cn/publicfiles/business/htmlfiles//publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/index2010.html. Last accessed March 1st 2015.
6. Baynam G, Walters M, Claes P, et al. Phenotyping: Targeting genotype's rich cousin for diagnosis. J Paediatr Child Health. 2015;51:381-6.
7. Houle D, Govindaraju DR, Omholt S. Phenomics: the next challenge. Nat rev Genet. 2010;11:855-66.
8. www.nhfpc.gov.cn/yzyb2b.shtml-2014-02-14. Last accessed April 22nd2015.
9. De Vrueh R, Baekelandt ERF, Haan JMH. Priority Medicines for Europe and the World." A Public Health approach to Innovation" Update on 2004 Background Paper. March 2013. http://www.who.int/medicines/areas/priority-medicines/BP6-19Rare.pdf. Accessed 26th April 2015
10. 61 EurodisCare2. Survey of diagnostic delays, 8 diseases, Europe. 2004. http://archive.eurordis.org/article.php3?id-article=454, Last accessed March 13th 2015.
11. Liu P, Li C, Zeng W, Wang H, Wu H, Lu J, et al. The impact of the major causes of death on life expectancy in China: a 60-year longitudinal study. BMC Public Health. 2014;14:1193. doi: 10.1186/1471-2458-14-1193.
12. Xu Y, Weifang Z, Yang R, Chaochun Z, Zhengyan Z. Infant mortality and life expectancy in China. Med Sci Monit. 2014;20:379-85.